PURExpress® Δ RF123 Kit

Catalog # Concentration Size List Price Quantity Your Price
E6850S 10 reactions $615.00
$553.50
E6850Z 1 set
Please Inquire
Catalog # Size List Price Your Price
E6850S 10 reactions $615.00
$553.50
E6850Z 1 set
Please Inquire
*On-line ordering is for Canadian customers only. Web pricing is applicable only to orders placed online at www.neb.ca

PURExpress® Δ RF123 kit is a variation of the PURExpress In vitro Protein Synthesis Kit where the release factors 1, 2 and 3 are omitted from the translation mix.

  • RF1, RF2 and RF3 are supplied separately to allow users to control protein synthesis with/without release factors of their choice
  • Essentially RF1 and RF3 free, RF2 is greatly reduced to minimal levels
  • Allows for robust recovery of activity-encoding nucleic acid template in library screening applications
  • Applications include non-natural amino acid incorporation, ribosome display and mRNA display

A rapid method for gene expression analysis, PURExpress® is a novel cell-free transcription/translation system reconstituted from the purified components necessary for E. coli translation. With minimal nuclease and protease activity, the PURExpress system preserves the integrity of DNA and RNA templates/complexes and results in proteins that are free of modification and degradation. Transcription and translation are carried out in a one-step reaction, and require the mixing of only two tubes. With results available in a few hours, PURExpress saves valuable laboratory time and is ideal for high throughput technologies.


PURExpress Citations


Figure 1: Protein expression using the PURExpress® In Vitro Protein Synthesis Kit. Figure 1: Protein expression using the PURExpress® In Vitro Protein Synthesis Kit.

25 μl reactions containing 250 ng template DNA and 20 units RNase Inhibitor were incubated at 37°C for 2 hours. 2.5 μl of each reaction was analyzed by SDS-PAGE using a 10–20% Tris-glycine gel. The red dot indicates the protein of interest. Marker M is the Protein Ladder (NEB #P7703, discontinued and replaced with NEB #P7717 ).
Figure 2: Incorporation of 35S-methionine enables visualizationof protein by autoradiography. Figure 2: Incorporation of 35S-methionine enables visualizationof protein by autoradiography.

25 μl reactions containing 250 ng template DNA, 20 units RNase Inhibitor and 2 μl 35S-met were incubated at 37°C for 2 hours. 2.5 μl of each reaction was analyzed by SDS-PAGE, the gel was fixed for 10 minutes, dried for 2 hours at 80°C and exposed to x-ray film for 5 hours at -80°C.
Figure 3: Schematic diagram of protein synthesis and purification by PURExpress. Figure 3: Schematic diagram of protein synthesis and purification by PURExpress.

Figure 4: Expression and reverse purification of DHFR (A) and T4 DNA Ligase (B) using PURExpress. Figure 4: Expression and reverse purification of DHFR (A) and T4 DNA Ligase (B) using PURExpress.
125 μl reactions were carried out according to recommendations in the accompanying manual. Samples were analyzed on a 10–20% Tris-glycine gel and stained with Coomassie Blue. Note that in both cases, the desired protein can be visualized in the total protein fraction. The red dot indicates the protein of interest. Marker M is the Protein Ladder (NEB #P7703, discontinued and replaced with NEB #P7717 ).
Reagents Supplied

The following reagents are supplied with this product:

NEB # Component Name Component # Stored at (°C) Amount Concentration
  PURExpress Solution A B0228AVIAL -80 1 x 0.1 ml 2.5 X
  PURExpress Solution B (Minus RF123) P6854AVIAL -80 1 x 0.075 ml
  RF1 (10 μl) P6851AVIAL -80 1 x 0.01 ml
  RF2 (10 μl) P6852AVIAL -80 1 x 0.01 ml
  RF3 (10 μl) P6853AVIAL -80 1 x 0.01 ml
  PURExpress Control DHFR Plasmid N0424AVIAL -20 1 x 0.01 ml 125 ng/µl
Application Features
  • Quickly generate analytical amounts of protein for further characterization
  • Confirmation of open reading frames
  • Examination of the effects of mutations on ORFs
  • Generation of truncated proteins to identify active domains and functional residues
  • Introduction of modified, unnatural or labeled amino acids
  • Epitope mapping
  • Expression of toxic proteins
  • Ribosome display
  • Translation and/or protein folding studies
  • In vitro compartmentalization

Properties & Usage

Materials Required but not Supplied

  • General:  37°C incubator
  • Labeling:  35S-Methionine (>1000 Ci/mmol recommended, in vitro translation grade)
  • TCA Precipitation:  TCA solutions (25%, 10%), 1 M NaOH, casamino acids, ethanol, glass fiber filters, vacuum filtration manifold
  • SDS-PAGE:  Gels and running buffer, gel apparatus, power supply, gel dryer
  • Western Blotting:  Transfer apparatus, membrane, antibodies and detection reagent
  • Purification:  Ni-NTA Agarose, Amicon Ultra- 0.5 ml, Ultracel- 100K Membrane Centrifugal Filters


Notes
  • For a positive control reaction, use 2 μl of the supplied DHFR control template and 0.5 μl each of the supplied release factors.
  • Each kit contains sufficient reagents for 10 x 25 µl reactions.
  • The three release factors are supplied separately, allowing users to perform a protein synthesis reaction/ribosome display experiment with/without release factors of their choice.
  • Release factors have not been added to solution B. You may still observe translational termination at a reduced level depending on your application and protein template design.
  • PURExpress DHFR Control Template sequence files: Fasta, GenBank
References
  • Hong, S. H., I. Ntai, et al. (2013). Cell-free Protein Synthesis from a Release Factor 1 Deficient Escherichia coli Activates Efficient and Multiple Site-specific Nonstandard Amino Acid Incorporation. ACS Synthetic Biology. 3(6), 398-409. PubMedID: 24328168
  • Kogure, H., Y. Handa, et al. (2013). Identification of residues required for stalled-ribosome rescue in the codon-independent release factor YaeJ. Nucleic Acids Research. 42(5), 3152-63. PubMedID: 24322300
Tech Tips
  • Thaw and assemble reactions on ice
    Thoroughly mix solutions A and B before using. Do not vortex Solution B or ribosomes, mix gently.
    Solution A may have a cloudy white appearance. Add to the reaction as a uniform suspension.
    Assemble the reactions in the following order on ice: Solution A, Solution B, RNAse Inhibitor, Water, Template DNA or RNA
    Once reaction is assembled take time to make sure everything is thoroughly mixed by gently pipetting up and down, pulse spin and place at 37C for 2 to 4 hours.
Quality Control Assay
Quality Control tests are performed on each new lot of NEB product to meet the specifications designated for it. Specifications and individual lot data from the tests that are performed for this particular product can be found and downloaded on the Product Specification Sheet, Certificate of Analysis, data card or product manual. Further information regarding NEB product quality can be found here.
Specifications
The Specification sheet is a document that includes the storage temperature, shelf life and the specifications designated for the product. The following file naming structure is used to name these document files: [Product Number]_[Size]_[Version]
Legal And Disclaimer

Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally developed. The use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications. For more information, please email busdev@neb.com.

This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.

New England Biolabs (NEB) is committed to practicing ethical science – we believe it is our job as researchers to ask the important questions that when answered will help preserve our quality of life and the world that we live in. However, this research should always be done in safe and ethical manner. Learn more.PURExpress® is based on the PURE System Technology originally developed by Dr. Takuya Ueda at the University of Tokyo and commercialized as the PURESYSTEM® by BioComber (Tokyo, Japan).

Licensed from BioComber (Tokyo, Japan) under Patent Nos. 7,118,883; WO2005-105994 and JP2006-340694. For research use only. Commercial use of PURExpress® In vitro Protein Synthesis Kit requires a license from New England Biolabs, Inc. This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals. 

Top